University of California, Davis, researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic’s therapeutic power with reduced hallucinogenic potential. The research, published in Proceedings of the National Academy of Sciences, highlights the new drug’s potential as a treatment option for conditions like schizophrenia, where psychedelics are not prescribed for safety reasons.
In its 116th year, Picnic Day is one of UC Davis’ most revered — and most fun! — traditions. From the amazing exhibits and yummy food, to the artistic and scientific demonstrations and everything in-between, here at the College of Letters and Science, we love this annual celebration.
UC Davis Professor of Chemistry Mark Mascal studies “pseudocannabinoids,” which are synthetic molecules that mimic the action of cannabinoids. Pseudocannabinoids can be completely synthesized from commercially available chemicals without the need for cultivating hemp, which can be land-, water- and energy-intensive.
The 25th R. Bryan Miller Symposium kicked off March 6 at the UC Davis Conference Center and ran through March 7. To commemorate the 25th anniversary, some members from the Department of Chemistry and Miller's family recently shared their thoughts on the symposium, retracing its founding and the legacy of its namesake.
In a new study appearing in JACS Au, UC Davis researchers harness the power of machine learning to improve the molecular interpretation of a spectroscopy technique that’s prominently used to investigate the air-ice interface, the critical boundary area for these chemical reactions.
A UC Davis researcher exploring the possibilities of quantum chemistry was recently awarded a five-year, $660,000 grant from the National Science Foundation’s Faculty Early Career Development Program (CAREER).
The University of California, Davis, is pleased to announce the autumn cohort of the Science Translation and Innovative Research (STAIR) Grant Program. The cohort includes Annaliese Franz, a professor in Department of Chemistry.
Imaging is imperative to molecular biology. To understand human health and disease, scientists need a molecular window into the processes underlying our biology.
Alum Lieza Danan, CEO and co-founder of LiVeritas Biosciences, discusses her journey in startups and life, including her years at UC Davis, where she earned a Ph.D. degree in biological chemistry in 2009.
New research shows that the anti-anxiety and hallucinogenic-like effects of a psychedelic drug work through different neural circuits. The study, in a mouse model, shows that it could be possible to separate treatment from hallucinations when developing new drugs based on psychedelics.
